Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients.
Hack CC, Häberle L, Brucker SY, Janni W, Volz B, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kuemmel S, Martin B, Thomssen C, Graf H, Wolf C, Lux MP, Bayer CM, Rauh C, Almstedt K, Gass P, Heindl F, Brodkorb T, Willer L, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Rack B, Beckmann MW, Fehm T, Rody A, Maass N, Hein A, Fasching PA, Nabieva N. Hack CC, et al. Among authors: fehm t. Breast. 2020 Apr;50:11-18. doi: 10.1016/j.breast.2019.12.017. Epub 2020 Jan 8. Breast. 2020. PMID: 31958661 Free PMC article. Clinical Trial.
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Löhberg CR, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K. Fehm T, et al. Breast Cancer Res Treat. 2010 Nov;124(2):403-12. doi: 10.1007/s10549-010-1163-x. Epub 2010 Sep 22. Breast Cancer Res Treat. 2010. PMID: 20859679 Clinical Trial.
Oncolytic virotherapy of gynecologic malignancies.
Hartkopf AD, Fehm T, Wallwiener D, Lauer U. Hartkopf AD, et al. Among authors: fehm t. Gynecol Oncol. 2011 Feb;120(2):302-10. doi: 10.1016/j.ygyno.2010.10.031. Epub 2010 Dec 8. Gynecol Oncol. 2011. PMID: 21145097 Review.
Fertility conservation in breast cancer patients.
Lawrenz B, Henes M, Neunhoeffer E, Kraemer B, Fehm T. Lawrenz B, et al. Among authors: fehm t. Womens Health (Lond). 2011 Mar;7(2):203-12. doi: 10.2217/whe.10.91. Womens Health (Lond). 2011. PMID: 21410346 Free article. Review.
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer.
Souchon R, Feyer P, Thomssen C, Fehm T, Diel I, Nitz U, Janni W, Bischoff J, Sauer R. Souchon R, et al. Among authors: fehm t. Breast Care (Basel). 2010 Dec;5(6):401-7. doi: 10.1159/000322661. Breast Care (Basel). 2010. PMID: 21494406 Free PMC article. Review.
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.
Aktas B, Müller V, Tewes M, Zeitz J, Kasimir-Bauer S, Loehberg CR, Rack B, Schneeweiss A, Fehm T. Aktas B, et al. Among authors: fehm t. Gynecol Oncol. 2011 Aug;122(2):356-60. doi: 10.1016/j.ygyno.2011.04.039. Epub 2011 May 24. Gynecol Oncol. 2011. PMID: 21605893
The concordance rate between ER, PR and HER2 status of CTCs and the primary tumor was 29%, 25% and 53%, respectively (Fehm T et al., Breast Cancer Res Aug 10 2009, 11(4) pR59). Based on these results we studied blood samples of 193 metastatic breast cancer patients …
The concordance rate between ER, PR and HER2 status of CTCs and the primary tumor was 29%, 25% and 53%, respectively (Fehm T e …
591 results